Ureteral Access Sheath Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

Ureteral access sheaths are tubular medical devices inserted through the urethra and bladder into the ureter during urological surgeries, primarily for kidney stone fragmentation and removal. The global market was valued at roughly $610 million in 2025 and is forecast to reach approximately $1.07 billion by 2033, reflecting a compound annual growth rate of about 7% over the projection period. The devices are predominantly single-use, polymer-based products classified by inner diameter and clinical application.

• •Global market valued at ~$610 million in 2025, projected to reach ~$1.07 billion by 2033
• •U.S. market estimated at ~$160 million in 2025, with a projected CAGR of 6.5% through 2033
• •Products segmented primarily by inner diameter (e.g., below 10 Fr and above) and clinical use case

The primary engine of market expansion is the rising global prevalence of urolithiasis, kidney stones, driven by dietary, lifestyle, and demographic factors. Concurrently, the worldwide shift toward minimally invasive surgical techniques has elevated demand for devices that reduce operative time, minimize ureteral trauma, and improve stone-free rates.

• •Increasing incidence of kidney stones and other urological disorders globally
• •Strong clinical preference for minimally invasive procedures over open surgery
• •Ongoing product innovation improving sheath flexibility, trackability, and patient comfort

The market is segmented by product type, distinguished largely by inner diameter, with sub-categories spanning diameters below and above 10 French, and by clinical end use in diagnostic versus therapeutic procedures. Geographically, North America accounts for the largest revenue share, with the U.S. dominating the regional picture, while Asia-Pacific is emerging as the fastest-growing regional market due to rising healthcare access and expanding surgical volumes.

• •Product segmentation by inner diameter (below 10 Fr vs. 10 Fr and above) and clinical end use
• •North America leads in market share, with the U.S. as the primary contributor
• •Asia-Pacific is expected to register the strongest regional growth rate

Who are the notable companies in the industry?

The market is characterized as highly competitive with the presence of a small number of established players, suggesting a moderately consolidated structure rather than a fragmented one. Competition spans both large diversified medical device manufacturers with broad urological portfolios and more focused specialty producers that concentrate on endourology product lines. Production relies on polymer extrusion and precision forming technologies, with most capacity concentrated in regions aligned with major medical device manufacturing hubs.

• •Market described as highly competitive with the presence of a few major players, indicating moderate consolidation
• •Competition exists between large integrated device manufacturers and specialty producers focused on urological instruments
• •Manufacturing is based on polymer-based production processes, with capacity concentrated in established medical device manufacturing regions

What are the recent trends and outlook?

The medium-term outlook supports continued above-average growth, driven by persistent demand for minimally invasive urological care and incremental product improvements. Variability in analyst projections, some sources citing a 7% CAGR and others a lower long-term rate, reflects differences in methodology and regional weighting, but the directional consensus is firmly positive.

• •Continued demand from aging populations and rising prevalence of urological conditions
• •Product innovation focused on improving insertion ease, patient safety, and procedural efficiency
• •Projected long-term growth supported by expanding healthcare infrastructure in emerging markets